Domark International (DOMK) 10-Q 28 Oct 13 2014 Q1 Quarterly report Financial data

Document_and_Entity_Informatio

Document and Entity Information	3 Months Ended
	Aug. 31, 2013
Document And Entity Information
Entity Registrant Name	Domark International Inc.
Entity Central Index Key	1365160
Document Type	10-Q
Document Period End Date	31-Aug-13
Amendment Flag	FALSE
Current Fiscal Year End Date	-26
Is Entity a Well-known Seasoned Issuer?	No
Is Entity a Voluntary Filer?	No
Is Entity's Reporting Status Current?	Yes
Entity Filer Category	Smaller Reporting Company
Entity Common Stock, Shares Outstanding	74,429,054
Document Fiscal Period Focus	Q1
Document Fiscal Year Focus	2014

Consolidated_Balance_Sheets

Consolidated Balance Sheets (USD $)	Aug. 31, 2013	31-May-13
CURRENT
Cash and cash equivalents	$13,663	$20
Prepaid expenses	17,822	17,823
TOTAL CURRENT ASSETS	31,485	17,843
INVESTMENTS	915,402
Other Assets
Loan receivable from consultant	36,203
Patents	75,500	40,000
License, net of accumulated amortization of $2,188 and $1,828, respectively	7,822	8,182
TOTAL OTHER ASSETS	119,525	48,182
TOTAL ASSETS	1,066,412	66,025
LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)
Accounts payable & accrued expenses	198,670	209,179
Loans payable to consultants and stockholders	245,393	45,288
Convertible notes payable (net of unamortized discounts of $248,498 and $59,301, respectively)	105,502	148,691
Derivative liability for convertible notes payable	520,852	237,578
TOTAL CURRENT LIABILITIES AND TOTAL LIABILITIES	1,070,417	640,736
STOCKHOLDERS' EQUITY (DEFICIT)
Preferred stock, $0.001 par value, authorized 10,000,000 shares: Series A convertible preferred stock - issued and outstanding 50,000 shares	50	50
Common stock, $0.001 par value, authorized 200,000,000 shares: issued and outstanding 74,429,054 and 54,615,298 shares, respectively	74,429	54,615
Common stock payable	858,000	858,000
Additional paid-in capital	42,130,942	40,816,440
Accumulated deficit	-26,850,830	-26,850,830
Accumulated deficit during development stage	-16,216,596	-15,452,986
TOTAL STOCKHOLDERS' EQUITY (DEFICIT)	-4,005	-574,711
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)	$1,066,412	$66,025

Consolidated_Balance_Sheets_Pa

Consolidated Balance Sheets (Parenthetical) (USD $)	Aug. 31, 2013	31-May-13
Consolidated Balance Sheets Parenthetical
License, net of accumulated amortization	$2,188	$1,828
Convertible notes payable net of unamortized discounts	$248,498	$59,301
STOCKHOLDERS' EQUITY (DEFICIT)
Preferred stock series A, par value	$0.00	$0.00
Preferred stock series A, shares authorized	10,000,000	10,000,000
Preferred stock series A, shares issued	50,000	50,000
Preferred stock series A, shares outstanding	50,000	50,000
Common Stock, par value	$0.00	$0.00
Common Stock, shares authorized	200,000,000	200,000,000
Common Stock, shares issued	74,429,054	54,615,298
Common Stock, shares outstanding	74,429,054	54,615,298

Consolidated_Statements_Of_Ope

Consolidated Statements Of Operations (Unaudited) (USD $)	3 Months Ended		46 Months Ended
	Aug. 31, 2013	Aug. 31, 2012	Aug. 31, 2013
Consolidated Statements Of Operations
Sales		$20,345	$57,864
Cost of sales		22,976	80,284
GROSS LOSS		-2,631	-22,420
Operating expenses:
General and administrative expenses	259,443	375,479	1,932,325
Stock-based compensation	453,825	410,550	7,321,341
Research & development			45,609
Amortization of Barefoot-Science license fee		394,520	1,394,520
Impairment of Barefoot-Science license fee			4,605,480
Depreciation & Amortization	360	2,619	14,901
Impairment of other assets			20,000
Bad debt expenses		1,000	101,456
Loss on settlement of debt			409,903
Total operating expenses	713,628	1,184,168	15,845,535
Loss from operations	-713,628	-1,186,799	-15,867,955
Other income (expense):
Other Income			29,567
Revaluation of derivative liability for convertible notes	14,976		-222,602
Interest expense	-64,958		-155,606
Total other income (expense)	-49,982		-348,641
Net loss	($763,610)	($1,186,799)	($16,216,596)
Net loss per common share, basic and diluted	($0.01)	($0.04)
Weighted average common shares outstanding	64,522,176	29,350,896

Consolidated_Statements_Of_Cas

Consolidated Statements Of Cash Flows (Unaudited) (USD $)	3 Months Ended		46 Months Ended
	Aug. 31, 2013	Aug. 31, 2012	Aug. 31, 2013
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss	($763,610)	($1,186,799)	($16,216,596)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	360	2,619	14,901
Amortization of deferred finance costs		14,799	60,000
Common stock issued a compensation	453,825	920,175	7,321,341
Non cash interest	64,958		70,603
Loss (gain) on derivative valuation	-14,976		222,602
Amortization of prepaid license fees			1,394,520
Impairment of assets			4,615,480
Loss on settlement of debt			409,903
Changes in Operating assets and liabilities:
Inventory - tv production		-13,611	-16,926
Prepaid expenses	1	11,020	-12,925
Accounts payable and accrued expenses	-10,509	49,416	367,975
Accounts payable -related party		25,442	15,366
Net cash in operating activities	-269,951	-176,939	-1,753,756
CASH FLOWS FROM INVESTING ACTIVITIES
Cash paid for licensing			-35,000
Cash paid for furniture & equipment			-4,000
Cash Paid for web development			-7,500
Cash paid for investments	-117,902		-117,902
Cash paid for loan receivable from consultant	-36,203		-36,203
Net cash flows used in investing activities	-154,105		-200,605
CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from convertible notes payable	282,500		392,500
Advances from related parties	155,199	153,722	1,242,887
Payments made on notes payable - related parties			-126,478
Proceeds received from notes payable			556,058
Payments made on notes payable			-100,470
Net cash provided by financing activities	437,699	153,722	1,964,497
Net increase(decrease) in cash and cash equivalants	13,643	-23,217	10,136
CASH BALANCE BEGINNING OF PERIOD	20	52,269	3,527
CASH BALANCE END OF PERIOD	13,663	29,052	13,663
Cash paid for interest
Cash paid for taxes
SUPPLEMENTAL SCHEDULE OF NON-CASH INVESTING AND FINANCING ACTIVITIES:
Prepaid licensing fee		6,000,000	6,000,000
Shares issued for note payable settlement	147,491		295,491
Shares issued for patent acquisition	35,500		75,500
Shares issued for 19% equity interest in Imagic Ltd	$697,500		$697,500

Description_of_Business

Description of Business	3 Months Ended
	Aug. 31, 2013
Notes to Financial Statements
Note 1 - Description of Business	DOMARK INTERNATIONAL, INC. ("DoMark" or the "Company") was incorporated under the laws of the State of Nevada on March 30, 2006. During 2008 and 2009, the Company acquired several operating businesses. On May 21, 2009, the Company entered into an acquisition agreement (the "Victory Lane Agreement") with Victory Lane Financial Elite, LLC ("Victory Lane") with respect to a real estate lifestyle business known as "Victory Lane" (the "Victory Lane Business"). Shortly thereafter, a dispute arose between the Company and the principals of Victory Lane regarding the representations of the principals of Victory Lane and the Victory Lane Business and the Victory Lane Agreement.
	On March 5, 2012, the Company entered into an Asset Purchase Agreement with its then controlling shareholder, R. Thomas Kidd, for the sale of the Company’s subsidiary Armada Armada/The Golf Championships and certain assets related thereto. The Company relied upon ASC 860-20-25, and ASC 860-20-40 to record the sale. Fair value of the transaction is measured at fair value of the assets less any liabilities sold.
	On February 29, 2012, the Company formed a new wholly owned subsidiary, Solawerks, Inc. in the state of Nevada, for the purposes of entering the business of marketing specialized solar consumer electronics. Solawerks' current focus is to develop and distribute the SolaPad: a combined cover and charging system for Apple's iPad, and the SolaCase: a combined cover and charging system for all versions of Apple's iPhone. Solawerks competes in a market that also includes 3D Systems (DDD), Dell (DELL) and Hewlett Packard (HPQ).
	On June 20, 2012, the Company formed a new wholly-owned subsidiary, MuscleFoot Inc. in the state of Nevada for the purpose of distributing, marketing, and acting as sales agent for the patented foot care system of Barefoot Science. This entity is currently in default with the Nevada Secretary of State.
	On July 20, 2012, the Company formed a new wholly-owned subsidiary, DoMark Canada Inc. in the province of Ontario for the purpose of supporting the Company’s corporate operations based in Toronto, Ontario, Canada.
	On February 28, 2013, the Company entered into a Memorandum of Understanding to purchase 44% of Zaktek Ltd. (“Zaktek”). Zaktek’s main product is the phonepad+, an Apple Inc. approved tablet device that works with smartphones, including the Apple iPhone® and Samsung Galaxy products to improve functionality including video and gaming abilities.
	On April 23, 2013, the Company received notification that Zaktek was ending discussions in regards to the definitive purchase agreement with DoMark.
	On June 11, 2013, the Company then purchased 100% of South Hill Ltd., an English private limited company, which owns approximately 19% of Zaktek.

Going_Concern

Going Concern	3 Months Ended
	Aug. 31, 2013
Notes to Financial Statements
Note 2 - Going Concern	The accompanying consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America which contemplate continuation of the Company as a going concern. The Company has year-end losses from operations of $6,745,015 and $5,533,923 for the years ended May 31, 2013 and 2012, respectively. Furthermore, the Company has inadequate working capital to maintain or develop its operations, and is dependent upon funds from private investors and the support of certain stockholders.
	These factors raise substantial doubt about the ability of the Company to continue as a going concern. These consolidated financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts, or amounts and classification of liabilities that might result from this uncertainty. In this regard, management is planning to raise any necessary additional funds through loans and additional sales of its common stock. There is no assurance that the Company will be successful in raising additional capital.

Basis_of_Presentation

Basis of Presentation	3 Months Ended
	Aug. 31, 2013
Notes to Financial Statements
Note 3 - Basis of Presentation	The audited consolidated financial statements of the Company have been prepared in accordance with United States generally accepted accounting principles ("GAAP") for financial information and the rules and regulations of the Securities and Exchange Commission ("SEC"). In the opinion of management, all adjustments, consisting of normal recurring accruals considered necessary for a fair presentation, have been included.

Summary_of_Significant_Account

Summary of Significant Accounting Policies	3 Months Ended
	Aug. 31, 2013
Notes to Financial Statements
Note 4 - Summary of Significant Accounting Policies	RECENT ACCOUNTNG PRONOUNCEMENTS
	The Company has reviewed recently issued accounting pronouncements and plans to adopt those that are applicable to it. It does not expect the adoption of these pronouncements to have a material impact on its financial position, results of operations or cash flows.
	DEVELOPMENT STAGE COMPANY
	The Company is a development stage company as defined in ASC Standard 915-10-05 and has recognized minimal revenue and devotes substantially all of its efforts on consumer electronic businesses. Its planned principal operations in developing its sports business have commenced. All losses accumulated since October 21, 2009 have been considered as part of the Company's development stage activities.
	PRINCIPLES OF CONSOLIDATION
	The accompanying consolidated financial statements represent the consolidated financial position and results of operations of the Company and include the accounts and results of operations of the Company and its subsidiaries. The accompanying consolidated financial statements include the active entity of DoMark International, Inc. and its wholly owned subsidiaries, DoMark Canada, Inc., Solawerks, Inc., Musclefoot, Inc., and South Hill Ltd. The Company has relied upon the guidance provided by Statements of Financial Accounting Standards, ASC 810-10-15-3.
	USE OF ESTIMATES
	The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements. These estimates and assumptions also affect the reported amounts of revenues, costs and expenses during the reporting period. Management evaluates these estimates and assumptions on a regular basis. Actual results could differ from those estimates.
	The primary management estimates included in these financial statements are the fair value of its stock tendered in various non-monetary transactions.
	CASH AND CASH EQUIVALENTS
	The Company considers all highly liquid investments with an original maturity of three months or less to be cash equivalents. At August 31, 2013 and May 31, 2013, cash and cash equivalents included cash on hand and cash in the bank.
	NET LOSS PER COMMON SHARE
	Basic net loss per common share is computed by dividing net loss by the weighted average number of shares of common stock outstanding during the period. Diluted net loss per common share is computed by dividing net loss by the weighted average number of shares of common stock and potentially outstanding shares of common stock during each period. Dilutive securities having an anti-dilutive effect on diluted net loss per common share are excluded from the calculation.
	For the three months ended August 31, 2013 and 2012, diluted common shares outstanding excluded the following dilutive securities as the effect of their inclusion was anti-dilutive:
		Three Months Ended
		August 31,
		2013		2012
	Convertible notes payable		13,435,345		-
	Series A convertible preferred stock		50,000,000		50,000,000
	Warrants		850,000		350,000
	Total		64,285,345		50,350,000
	INTANGIBLE ASSETS
	Intangible assets are carried at cost less accumulated amortization. Amortization is recorded over the estimated useful lives of the respective assets.
	IMPAIRMENT OF LONG-LIVED ASSETS
	In accordance with ASC Standard 360-10-40, long-lived assets, such as property, plant, and equipment, and purchased intangibles, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Goodwill and other intangible assets are tested for impairment annually. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to estimated undiscounted future cash flows expected to be generated by the asset. If the carrying amount of an asset exceeds its estimated future cash flows, an impairment charge is recognized by the amount by which the carrying amount of the asset exceeds the fair value of the asset.
	STOCK-BASED COMPENSATION
	The Company accounts for share based payments in accordance with ASC 718, Compensation - Stock Compensation, which requires all share-based payments to employees, including grants of employee stock options, to be recognized in the financial statements based on the grant date fair value of the award. In accordance with ASC 718-10-30-9, Measurement Objective - Fair Value at Grant Date, the Company estimates the fair value of the award using a valuation technique. For this purpose, the Company uses the Black-Scholes option pricing model. The Company believes this model provides the best estimate of fair value due to its ability to incorporate inputs that change over time, such as volatility and interest rates, and to allow for actual exercise behavior of option holders. Compensation cost is recognized over the requisite service period which is generally equal to the vesting period. Upon exercise, shares issued will be newly issued shares from authorized common stock.
	ASC 505, "Compensation-Stock Compensation", establishes standards for the accounting for transactions in which an entity exchanges its equity instruments to non-employees for goods or services. Under this method, stock compensation expense includes compensation expense for all stock-based compensation awards granted on or after January 1, 2006, based on the grant-date fair value estimated in accordance with the provisions of ASC 505.
	RESEARCH AND DEVELOPMENT
	All research and development expenditures are expensed as incurred.
	REVENUE RECOGNITION
	The Company recognizes revenues when persuasive evidence of an arrangement exists, delivery and acceptance has occurred or service has been rendered, the price is fixed or determinable, and collection of the resulting receivable is reasonably assured.

Investments

Investments	3 Months Ended
	Aug. 31, 2013
Notes to Financial Statements
Note 5 - Investments	Investments consist of:
		August 31,		May 31,
		2013		2013
	Imagic Ltd. - 19% equity interest - at cost (7,500,000 shares of	$	900,637	$	-
	DoMark common stock - $697,500, cash -$103,137, loans payable -$100,000)
	Barefoot Science Products & Services Inc. - 15% equity interest		14,765		-
	Total	$	915,402	$	-
	On July 22, 2013, the Company closed on the acquisition of a 19% equity interest in Imagic Ltd. (“Imagic”). Imagic is a privately owned company registered in Gibraltar which owns proprietary product designs for its Digilink and Game Control products. Imagic shares are not quoted or traded on any securities exchange or in any recognized over-the counter market. Accordingly, it is not practicable to estimate the fair value of this investment.
	On January 25, 2013, the Company executed an agreement with Barefoot Science Products & Services Inc. (“Barefoot Science”) which cancelled the Marketing and Distribution Agreement dated June 20, 2012 and which provided the Company a 15% equity interest in Barefoot Science. As a result, the Company recognized an impairment charge of $4,605,480 in the year ended May 31, 2013 to write off the remaining unamortized prepaid license fees at February 28, 2013 ($4,605,480). Barefoot Science has developed a patented foot strengthening system through insertion of an insole system or by incorporation right into the design of shoes. Barefoot Science shares are not quoted or traded on any securities exchange or in any recognized over-the counter market. Accordingly, it is not practicable to estimate the fair value of this investment.

Loans_Payable_to_Consultants_a

Loans Payable to Consultants and Stockholders	3 Months Ended
	Aug. 31, 2013
Notes to Financial Statements
NOTE 6 - Loans Payable to Consultants and Stockholders	Loans payable to consultants and stockholders consist of:
		August 31,		May 31,
		2013		2013
	Consultant and stockholder	$	50,000	$	-
	Consultant and stockholder		43,800		7,800
	Chairman of DoMark		36,500		-
	Chairman of Barefoot Science and affiliate		33,500		-
	Consultant		12,996		-
	Consultant		68,597		37,488
	Total	$	245,393	$	45,288
	The loans are informal and do not provide for interest or a stated maturity date.

Convertible_Notes_Payable

Convertible Notes Payable	3 Months Ended
	Aug. 31, 2013
Notes to Financial Statements
Note 7 - Convertible Notes Payable	At August 31, 2013, convertible notes payable consisted of
	Date of Note	Noteholder	Interest			Maturity	Principal		Unamortized			Net Carrying Amount
			Rate			date	Amount		Debt Discount
	1/30/13	Asher Enterprises, Inc.		8	%	11/1/13	$	39,000(a)	$	(39,000	)	$	78,000
	4/15/13	Asher Enterprises, Inc.		8	%	1/17/14		32,500(a)		27,111			5,209
	6/11/13	Asher Enterprises, Inc.		8	%	3/3/14		32,500(a)		31,712			788
	8/1/13	Continental Equities, LLC		12	%	8/1/14		30,000(b)		29,969			31
	8/5/13	JSJ Investments, Inc.		10	%	02/05/14		25,000(c)		24,969			31
	8/7/13	JMJ Financial Inc.		12	%	8/7/14		50,000 (d)		33,288			16,712
	8/13/13	Black Mountain Equities, Inc.		10	%	5/13/14		50,000 (e)		45,459			4,541
	8/26/13	Redwood Fund III		12	%	2/28/14		95,000 (f)		94,990			10
	Totals						$	354,000	$	248,498		$	105,502
	Legend
	(a)   At noteholder’s option, the principal amount (and accrued interest) are convertible into shares of DoMark common stock at a conversion price equal to 55% of the average of the two lowest closing prices during the 15 trading days prior to the notice of conversion.
	(b)   At noteholder’s option, the principal amount (and accrued interest) are convertible into shares of DoMark common stock at a conversion price equal to 50% of the average of the three lowest closing prices during the 30 trading days prior to the notice of conversion.
	(c)   At noteholder’s option, the principal amount (and accrued interest) are convertible into shares of DoMark common stock at a conversion price equal to the lower of $0.081 or 50% of the average of the three lowest closing prices during the 10 trading days prior to the notice of conversion.
	(d)   At noteholder’s option, the principal amount (and accrued interest) are convertible into shares of DoMark common stock at a conversion price equal to the lower of $0.085 or 60% of the lowest closing price during the 25 trading days prior to the notice of conversion.
	(e)   At noteholder’s option, the principal amount (and accrued interest) are convertible into shares of DoMark common stock at a conversion price equal to the lower of $0.08 or 50% of the lowest closing price during the 10 trading days prior to the notice of conversion.
	(f)   At noteholder’s option, the principal amount (and accrued interest) are convertible into shares of DoMark common stock at a conversion price equal to the lower of $0.0725 or 34% of the lowest closing price during the 20 trading days prior to the notice of conversion.

Stockholders_Equity

Stockholders Equity	3 Months Ended
	Aug. 31, 2013
Notes to Financial Statements
Note 8 - Stockholders Equity	Series A Convertible Preferred Stock
	Each share of Series A Convertible Preferred Stock has 1000 voting rights and is convertible into 1000 shares of common stock.
	Common Stock Issuances
	On June 17, 2013, the Company issued 2,500,000 shares of common stock in satisfaction of a $50,000 loan payable.
	On June 29, 2013, the Company issued 2,500,000 shares of common stock (valued at $250,000) to a consultant for services rendered.
	On July 5, 2013, the Company issued 250,000 shares of common stock (valued at $22,500) to a consultant for website development services.
	On July 9, 2013, the Company issued 75,000 shares of common stock (valued at $6,675) to a consultant for services rendered.
	On July 17, 2013, the Company issued 500,000 shares of common stock (valued at $41,650) to a consultant for investor relations services.
	On July 22, 2013, the Company issued 2,874,550 shares of common stock in satisfaction of a $57,491 loan payable.
	On July 22, 2013, the Company issued 7,500,000 shares of common stock (valued at $697,500) in connection with the acquisition of a 19% equity interest in Imagic Ltd. See Note 5.
	On August 15, 2013, the Company issued 500,000 shares of common stock (valued at $35,500) to Bioharmonics Technologies Corp. in connection with the acquisition of certain inventions and related patents and patent applications. See Note 9.
	On August 26, 2013, the Company issued 2,000,000 shares of common stock (valued at $133,000) to a consultant for services rendered.
	On August 28, 2013, the Company issued 1,114,206 shares of common stock to Asher Enterprises, inc. in satisfaction of $14,000 principal amount of convertible notes payable and $26,000 of fees. See Note 7.
	Warrants to Purchase Common Stock
	A summary of warrant activity for the year ended May 31, 2013 and for the three months ended August 31, 2013 follows:
					Weighted Average Exercise Price
		Number of Warrants
	Outstanding at May 31, 2012		-		$	-
	Granted		850,000			0.42
	Exercised		-			-
	Cancelled		-			-
	Outstanding at May 31, 2013		850,000			0.42
	Granted		-			-
	Exercised		-			-
	Cancelled		-			-
	Outstanding at August 31, 2013		850,000		$	0.42
	Warrants outstanding at August 31, 2013 consist of:
	Date Granted		Number Outstanding			Exercise		Expiration
						price		Date
	25-May-12			100,000		$	1	25-May-15
	12-Jun-12			150,000		$	1	12-Jun-15
	26-Jun-12			100,000		$	1	26-Jun-15
	1-Jan-13			500,000		$	0.01	1-Jan-15
	Totals			850,000

Commitments_and_Contingencies

Commitments and Contingencies	3 Months Ended
	Aug. 31, 2013
Notes to Financial Statements
Note 9 - Commitments and Contingencies	License Agreements
	On February 29, 2012, the Company entered into a Memorandum of Agreement with Xiamen Taiyang Neng Gongsi and Michael Franklin. For and in consideration of the payment of an initial license fee of $10,000, and for the future payment of royalties of $5.00 per SolaPad unit sold, Xiamen granted an exclusive worldwide license and joint patent rights to the Company for a solar charging case for IPAD, including IPAD 3. The license under the Agreement expires on December 31, 2018.
	On April 19, 2013, our subsidiary DoMark Canada Inc. executed an agreement with Bioharmonics Technologies Cop. (“Bioharmoniecs”). The agreement provided for the acquisition of certain inventions and related patents and patent applications in exchange for 500,000 shares of DoMark common stock (which was delivered April 19, 2013 and valued at $40,000) and $30,000 cash payable no later than October 17, 2013 (which was satisfied through the delivery of an additional 500,000 shares of DoMark common stock to Bioharmonics on August 15, 2013 valued at $35,500). The agreement also provides for a royalty obligation payable quarterly to Bioharmonics equal to 10% of the wholesale price for each unit using infrared and solar charging.
	Employment Agreements
	On May 25, 2012, the Company entered into an employment agreement with its President, R. Brentwood Strasler, for an indefinite period or until terminated. Mr. Strasler is entitled to an annual salary of $150,000 and 100,000 stock purchase warrants exercisable to purchase shares of common stock of the Company at $1.00 per share. The warrants are exercisable for a three year period and can be vested quarterly on a pro rata basis over twelve months from the date of issue. Additionally, Mr. Strasler is to be enrolled in a long term Executive Option Plan and is entitled to term life insurance in the face amount of $2,500,000, payable to the beneficiary designated by Mr. Strasler.
	On June 15, 2012, the Company entered into an employment agreement with its Chief Executive Officer Andrew Ritchie, for an indefinite period or until terminated. Mr. Ritchie is entitled to an annual salary of $240,000 and 150,000 stock purchase warrants exercisable to purchase shares of common stock of the Company at $1.00 per share. The warrants are exercisable for a three year period and can be vested quarterly on a pro rata basis over twelve months from the date of issue. Additionally, Mr. Ritchie is to be enrolled in a long term Executive Option Plan and is entitled to term life insurance in the face amount of $2,500,000, payable to the beneficiary designated by Mr. Richie.
	Lease Agreement
	On August 1, 2013 the Company entered into an office lease in Toronto, Ontario, Canada for a five year period. The future lease commitments on this lease for the years ended May 31, are as follows:
	2014	$	17,174
	2015		22,899
	2016		25,143
	2017		25,593
	2018		25,593
	Total	$	116,402

Summary_of_Significant_Account1

Summary of Significant Accounting Policies (Policies)	3 Months Ended
	Aug. 31, 2013
Summary Of Significant Accounting Policies Policies
Recent Accountng Pronouncements	The Company has reviewed recently issued accounting pronouncements and plans to adopt those that are applicable to it. It does not expect the adoption of these pronouncements to have a material impact on its financial position, results of operations or cash flows.
Development Stage Company	The Company is a development stage company as defined in ASC Standard 915-10-05 and has recognized minimal revenue and devotes substantially all of its efforts on consumer electronic businesses. Its planned principal operations in developing its sports business have commenced. All losses accumulated since October 21, 2009 have been considered as part of the Company's development stage activities.
Principles of Consolidation	The accompanying consolidated financial statements represent the consolidated financial position and results of operations of the Company and include the accounts and results of operations of the Company and its subsidiaries. The accompanying consolidated financial statements include the active entity of DoMark International, Inc. and its wholly owned subsidiaries, DoMark Canada, Inc., Solawerks, Inc., Musclefoot, Inc., and South Hill Ltd. The Company has relied upon the guidance provided by Statements of Financial Accounting Standards, ASC 810-10-15-3.
Use of Estimates	The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements. These estimates and assumptions also affect the reported amounts of revenues, costs and expenses during the reporting period. Management evaluates these estimates and assumptions on a regular basis. Actual results could differ from those estimates.
	The primary management estimates included in these financial statements are the fair value of its stock tendered in various non-monetary transactions.
Cash and Cash Equivalents	The Company considers all highly liquid investments with an original maturity of three months or less to be cash equivalents. At August 31, 2013 and May 31, 2013, cash and cash equivalents included cash on hand and cash in the bank.
Net Loss Per Common Share	Basic net loss per common share is computed by dividing net loss by the weighted average number of shares of common stock outstanding during the period. Diluted net loss per common share is computed by dividing net loss by the weighted average number of shares of common stock and potentially outstanding shares of common stock during each period. Dilutive securities having an anti-dilutive effect on diluted net loss per common share are excluded from the calculation.
	For the three months ended August 31, 2013 and 2012, diluted common shares outstanding excluded the following dilutive securities as the effect of their inclusion was anti-dilutive:
		Three Months Ended
		August 31,
		2013		2012
	Convertible notes payable		13,435,345		-
	Series A convertible preferred stock		50,000,000		50,000,000
	Warrants		850,000		350,000
	Total		64,285,345		50,350,000
Intangible Assets	Intangible assets are carried at cost less accumulated amortization. Amortization is recorded over the estimated useful lives of the respective assets.
Impairment of Long-Lived Assets	In accordance with ASC Standard 360-10-40, long-lived assets, such as property, plant, and equipment, and purchased intangibles, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Goodwill and other intangible assets are tested for impairment annually. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to estimated undiscounted future cash flows expected to be generated by the asset. If the carrying amount of an asset exceeds its estimated future cash flows, an impairment charge is recognized by the amount by which the carrying amount of the asset exceeds the fair value of the asset.
Stock Based Compensation	The Company accounts for share based payments in accordance with ASC 718, Compensation - Stock Compensation, which requires all share-based payments to employees, including grants of employee stock options, to be recognized in the financial statements based on the grant date fair value of the award. In accordance with ASC 718-10-30-9, Measurement Objective - Fair Value at Grant Date, the Company estimates the fair value of the award using a valuation technique. For this purpose, the Company uses the Black-Scholes option pricing model. The Company believes this model provides the best estimate of fair value due to its ability to incorporate inputs that change over time, such as volatility and interest rates, and to allow for actual exercise behavior of option holders. Compensation cost is recognized over the requisite service period which is generally equal to the vesting period. Upon exercise, shares issued will be newly issued shares from authorized common stock.
	ASC 505, "Compensation-Stock Compensation", establishes standards for the accounting for transactions in which an entity exchanges its equity instruments to non-employees for goods or services. Under this method, stock compensation expense includes compensation expense for all stock-based compensation awards granted on or after January 1, 2006, based on the grant-date fair value estimated in accordance with the provisions of ASC 505.
Research and Development	All research and development expenditures are expensed as incurred.
Revenue Recognition	The Company recognizes revenues when persuasive evidence of an arrangement exists, delivery and acceptance has occurred or service has been rendered, the price is fixed or determinable, and collection of the resulting receivable is reasonably assured.

Summary_of_Significant_Account2

Summary of Significant Accounting Policies (Tables)	3 Months Ended
	Aug. 31, 2013
Summary Of Significant Accounting Policies Tables
Net Loss Per Common Share	For the three months ended August 31, 2013 and 2012, diluted common shares outstanding excluded the following dilutive securities as the effect of their inclusion was anti-dilutive:
		Three Months Ended
		August 31,
		2013		2012
	Convertible notes payable		13,435,345		-
	Series A convertible preferred stock		50,000,000		50,000,000
	Warrants		850,000		350,000
	Total		64,285,345		50,350,000

Investments_Tables

Investments (Tables)	3 Months Ended
	Aug. 31, 2013
Investments Tables
Investments		August 31,		May 31,
		2013		2013
	Imagic Ltd. - 19% equity interest - at cost (7,500,000 shares of	$	900,637	$	-
	DoMark common stock - $697,500, cash -$103,137, loans payable -$100,000)
	Barefoot Science Products & Services Inc. - 15% equity interest		14,765		-
	Total	$	915,402	$	-

Loans_Payable_to_Consultants_a1

Loans Payable to Consultants and Stockholders (Tables)	3 Months Ended
	Aug. 31, 2013
Loans Payable To Consultants And Stockholders Tables
Loans payable to consultants and stockholders	Loans payable to consultants and stockholders consist of:
		August 31,		May 31,
		2013		2013
	Consultant and stockholder	$	50,000	$	-
	Consultant and stockholder		43,800		7,800
	Chairman of DoMark		36,500		-
	Chairman of Barefoot Science and affiliate		33,500		-
	Consultant		12,996		-
	Consultant		68,597		37,488
	Total	$	245,393	$	45,288

Convertible_Notes_Payable_Tabl

Convertible Notes Payable (Tables)	3 Months Ended
	Aug. 31, 2013
Convertible Notes Payable Tables
Convertible notes payable	At August 31, 2013, convertible notes payable consisted of
	Date of Note	Noteholder	Interest			Maturity	Principal		Unamortized			Net Carrying Amount
			Rate			date	Amount		Debt Discount
	1/30/13	Asher Enterprises, Inc.		8	%	11/1/13	$	39,000(a)	$	(39,000	)	$	78,000
	4/15/13	Asher Enterprises, Inc.		8	%	1/17/14		32,500(a)		27,111			5,209
	6/11/13	Asher Enterprises, Inc.		8	%	3/3/14		32,500(a)		31,712			788
	8/1/13	Continental Equities, LLC		12	%	8/1/14		30,000(b)		29,969			31
	8/5/13	JSJ Investments, Inc.		10	%	02/05/14		25,000(c)		24,969			31
	8/7/13	JMJ Financial Inc.		12	%	8/7/14		50,000 (d)		33,288			16,712
	8/13/13	Black Mountain Equities, Inc.		10	%	5/13/14		50,000 (e)		45,459			4,541
	8/26/13	Redwood Fund III		12	%	2/28/14		95,000 (f)		94,990			10
	Totals						$	354,000	$	248,498		$	105,502

Stockholders_Equity_Tables

Stockholders Equity (Tables)	3 Months Ended
	Aug. 31, 2013
Stockholders Equity Tables
Summary of warrant activity					Weighted Average Exercise Price
		Number of Warrants
	Outstanding at May 31, 2012		-		$	-
	Granted		850,000			0.42
	Exercised		-			-
	Cancelled		-			-
	Outstanding at May 31, 2013		850,000			0.42
	Granted		-			-
	Exercised		-			-
	Cancelled		-			-
	Outstanding at August 31, 2013		850,000		$	0.42
Warrants outstanding	Warrants outstanding at August 31, 2013 consist of:
	Date Granted		Number Outstanding			Exercise		Expiration
						price		Date
	25-May-12			100,000		$	1	25-May-15
	12-Jun-12			150,000		$	1	12-Jun-15
	26-Jun-12			100,000		$	1	26-Jun-15
	1-Jan-13			500,000		$	0.01	1-Jan-15
	Totals			850,000

Commitments_and_Contingencies_

Commitments and Contingencies (Tables)	3 Months Ended
	Aug. 31, 2013
Commitments And Contingencies Tables
Future Lease Commitments	The future lease commitments on this lease are as follows;
	F/Y ending 5-31-2014	$	19,082
	F/Y ending 5-31-2015	$	22,899
	F/Y ending 5-31-2016	$	25,143
	F/Y ending 5-31-2017	$	25,593
	F/Y ending 5-31-2018	$	25,593
		$	118,310

Going_Concern_Details_Narrativ

Going Concern (Details Narrative) (USD $)	12 Months Ended
	31-May-13	31-May-12
Going Concern Details Narrative
Loss from operation	$6,745,015	$5,533,923

Summary_of_Significant_Account3

Summary of Significant Accounting Policies (Details)	3 Months Ended
	Aug. 31, 2013	Aug. 31, 2012
Summary Of Significant Accounting Policies Details
Convertible notes payable	13,435,345
Series A convertible preferred stock	50,000,000	50,000,000
Warrants	850,000	350,000
Total	64,285,345	50,350,000

Investments_Details

Investments (Details) (USD $)	Aug. 31, 2013	31-May-13
Investments Details
Imagic Ltd. - 19% equity interest - at cost (7,500,000 shares of DoMark common stock - $697,500, cash -$103,137, loans payable - $100,000)	$900,637
Barefoot Science Products & Services Inc. - 15% equity interest	14,765
Total	$915,402

Investments_Details_Narrative

Investments (Details Narrative) (USD $)	3 Months Ended		12 Months Ended	46 Months Ended
	Aug. 31, 2013	Aug. 31, 2012	31-May-13	Aug. 31, 2013
Investments Details Narrative
Impairment charge			$4,605,480	$4,605,480

Loans_Payable_to_Consultants_a2

Loans Payable to Consultants and Stockholders (Details) (USD $)	Aug. 31, 2013	31-May-13
Loans payable to consultants and stockholders	$245,393	$45,288
Consultant And Stockholder [Member]
Loans payable to consultants and stockholders	50,000
Consultant And Stockholder One [Member]
Loans payable to consultants and stockholders	43,800	7,800
Chairman of DoMark [Member]
Loans payable to consultants and stockholders	36,500
Chairman Of Barefoot Science And Affiliate [Member]
Loans payable to consultants and stockholders	33,500
Consultant [Member]
Loans payable to consultants and stockholders	12,996
Consultant One [Member]
Loans payable to consultants and stockholders	$68,597	$37,488

Convertible_Notes_Payable_Deta

Convertible Notes Payable (Details) (USD $)	Aug. 31, 2013		31-May-13
Principal Amount	$354,000
Unamortized Debt Discount	248,498		59,301
Net Carrying Amount	105,502		148,691
Asher Enterprises Inc. [Member]
Date of Note	1/30/13
Interest Rate	8.00%
Maturity date	11/1/13
Principal Amount	39,000	[1]
Unamortized Debt Discount	-39,000
Net Carrying Amount	78,000
Asher Enterprises Inc One [Member]
Date of Note	4/15/13
Interest Rate	8.00%
Maturity date	1/17/14
Principal Amount	32,500	[1]
Unamortized Debt Discount	27,111
Net Carrying Amount	5,209
Asher Enterprises Inc. Two [Member]
Date of Note	6/11/13
Interest Rate	8.00%
Maturity date	3/3/14
Principal Amount	32,500	[1]
Unamortized Debt Discount	31,712
Net Carrying Amount	788
Continental Equities LLC [Member]
Date of Note	8/1/13
Interest Rate	12.00%
Maturity date	8/1/14
Principal Amount	30,000	[2]
Unamortized Debt Discount	29,969
Net Carrying Amount	31
JSJ Investments Inc. [Member]
Date of Note	8/5/13
Interest Rate	10.00%
Maturity date	2/5/14
Principal Amount	25,000	[3]
Unamortized Debt Discount	24,969
Net Carrying Amount	31
JMJ Financial Inc. [Member]
Date of Note	8/7/13
Interest Rate	12.00%
Maturity date	8/7/14
Principal Amount	50,000	[4]
Unamortized Debt Discount	33,288
Net Carrying Amount	16,712
Black Mountain Equities Inc. [Member]
Date of Note	8/13/13
Interest Rate	10.00%
Maturity date	5/13/14
Principal Amount	50,000	[5]
Unamortized Debt Discount	45,459
Net Carrying Amount	4,541
Redwood Fund III [Member]
Date of Note	8/26/13
Interest Rate	12.00%
Maturity date	2/28/14
Principal Amount	95,000	[6]
Unamortized Debt Discount	94,990
Net Carrying Amount	$10
[1]	(a) At noteholders option, the principal amount (and accrued interest) are convertible into shares of DoMark common stock at a conversion price equal to 55% of the average of the two lowest closing prices during the 15 trading days prior to the notice of conversion.
[2]	(b) At noteholders option, the principal amount (and accrued interest) are convertible into shares of DoMark common stock at a conversion price equal to 50% of the average of the three lowest closing prices during the 30 trading days prior to the notice of conversion.
[3]	(c) At noteholders option, the principal amount (and accrued interest) are convertible into shares of DoMark common stock at a conversion price equal to the lower of $0.081 or 50% of the average of the three lowest closing prices during the 10 trading days prior to the notice of conversion.
[4]	(d) At noteholders option, the principal amount (and accrued interest) are convertible into shares of DoMark common stock at a conversion price equal to the lower of $0.085 or 60% of the lowest closing price during the 25 trading days prior to the notice of conversion.
[5]	(e) At noteholders option, the principal amount (and accrued interest) are convertible into shares of DoMark common stock at a conversion price equal to the lower of $0.08 or 50% of the lowest closing price during the 10 trading days prior to the notice of conversion.
[6]	(f) At noteholders option, the principal amount (and accrued interest) are convertible into shares of DoMark common stock at a conversion price equal to the lower of $0.0725 or 34% of the lowest closing price during the 20 trading days prior to the notice of conversion.

Shareholders_Equity_Details

Shareholders Equity (Details) (USD $)	3 Months Ended	12 Months Ended
	Aug. 31, 2013	31-May-13
Shareholders Equity Details
Outstanding Number of Warrants, Beginning Balance	850,000
Granted		850,000
Exercised
Cancelled
Outstanding Number of Warrants, Ending Balance	850,000	850,000
Weighted Average Exercise Price, Beginning Balance	$0.42
Granted		$0.42
Exercised
Cancelled
Weighted Average Exercise Price, Ending Balance	$0.42	$0.42

Stockholders_Equity_Details1

Stockholders Equity (Details1) (USD $)	Aug. 31, 2013	31-May-13	31-May-12
Number Of Warrant Outstanding	850,000	850,000
Warrant [Member]
Date Granted	25-May-12
Number Of Warrant Outstanding	100,000
Exercise price	1
Expiration Date	25-May-15
Warrant One [Member]
Date Granted	12-Jun-12
Number Of Warrant Outstanding	150,000
Exercise price	1
Expiration Date	12-Jun-15
Warrant Two [Member]
Date Granted	26-Jun-12
Number Of Warrant Outstanding	100,000
Exercise price	1
Expiration Date	26-Jun-15
Warrant Three [Member]
Date Granted	1-Jan-13
Number Of Warrant Outstanding	500,000
Exercise price	0.01
Expiration Date	1-Jan-15

Shareholders_Equity_Details_Na

Shareholders Equity (Details Narrative) (USD $)	Aug. 31, 2013	31-May-13
Common Stock, shares issued	74,429,054	54,615,298
Principal amount of convertible notes payable	$354,000
On June 17, 2013 [Member]
Common Stock, shares issued	2,500,000
Loan payable	50,000
On June 29, 2013 [Member]
Common Stock, shares issued	2,500,000
Value of share	250,000
On July 5, 2013 [Member]
Common Stock, shares issued	250,000
Value of share	22,500
On July 9, 2013 [Member]
Common Stock, shares issued	75,000
Value of share	6,675
On July 17, 2013 [Member]
Common Stock, shares issued	500,000
Value of share	41,650
On July 22, 2013 [Member]
Common Stock, shares issued	2,874,550
Loan payable	57,491
On July 22, 2013 One [Member]
Common Stock, shares issued	7,500,000
Value of share	697,500
On August 15, 2013 [Member]
Common Stock, shares issued	500,000
Value of share	35,500
On August 26, 2013 [Member]
Common Stock, shares issued	2,000,000
Value of share	133,000
On August 28, 2013 [Member]
Common Stock, shares issued	1,114,206
Principal amount of convertible notes payable	14,000
Fees	$26,000

Commitments_and_Contingencies_1

Commitments and Contingencies (Details) (USD $)	31-May-13
Commitments And Contingencies Details
2014	$17,174
2015	22,899
2016	25,143
2017	25,593
2018	25,593
Total	$116,402